Quarter Period Statement Of Income

K Pharma,Inc. - Filing #7543861

Concept	2023-01-01 to 2023-06-30	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31
Quarter period statement of income
Statement of income
Net sales	1,000,000,000 JPY	—	—	—	—	—	—	—	—
Cost of sales	90,000,000 JPY	—	—	—	—	—	—	—	—
Gross profit (loss)	910,000,000 JPY	—	—	—	—	—	—	—	—
Selling, general and administrative expenses	258,890,000 JPY	—	—	353,772,000 JPY	—	219,491,000 JPY	—	—	—
Selling, general and administrative expenses
Operating profit (loss)	651,109,000 JPY	—	—	-353,772,000 JPY	—	-219,491,000 JPY	—	—	—
Non-operating income
Interest income	7,000 JPY	—	—	7,000 JPY	—	1,000 JPY	—	—	—
Non-operating income	7,000 JPY	—	—	52,000 JPY	—	1,000 JPY	—	—	—
Non-operating expenses
Non-operating expenses	90,000 JPY	—	—	5,514,000 JPY	—	1,403,000 JPY	—	—	—
Ordinary profit (loss)	651,026,000 JPY	—	—	-359,233,000 JPY	—	-220,892,000 JPY	—	—	—
Extraordinary losses
Impairment losses	36,497,000 JPY	—	—	31,293,000 JPY	—	8,226,000 JPY	—	—	—
Extraordinary losses	36,497,000 JPY	—	—	31,293,000 JPY	—	8,226,000 JPY	—	—	—
Profit (loss) before income taxes	614,528,000 JPY	—	—	-390,526,000 JPY	—	-229,119,000 JPY	—	—	—
Income taxes - current	99,755,000 JPY	—	—	1,900,000 JPY	—	579,000 JPY	—	—	—
Income taxes - deferred	—	—	—	JPY	—	-980,000 JPY	—	—	—
Income taxes	99,755,000 JPY	—	—	1,900,000 JPY	—	-400,000 JPY	—	—	—
Profit (loss)	514,772,000 JPY	-392,427,000 JPY	-392,427,000 JPY	-392,427,000 JPY	-392,427,000 JPY	-228,718,000 JPY	-228,718,000 JPY	-228,718,000 JPY	-228,718,000 JPY